1. Home
  2. ENTA vs ISOU Comparison

ENTA vs ISOU Comparison

Compare ENTA & ISOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.85

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

ISOU

IsoEnergy Ltd.

HOLD

Current Price

$11.65

Market Cap

501.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
ISOU
Founded
1995
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
501.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
ISOU
Price
$12.85
$11.65
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
283.1K
98.1K
Earning Date
02-09-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,324,000.00
N/A
Revenue This Year
$0.99
N/A
Revenue Next Year
$0.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.09
$4.52
52 Week High
$17.15
$12.08

Technical Indicators

Market Signals
Indicator
ENTA
ISOU
Relative Strength Index (RSI) 41.35 68.20
Support Level $12.09 $10.77
Resistance Level $13.98 $12.08
Average True Range (ATR) 0.73 0.73
MACD -0.22 0.10
Stochastic Oscillator 19.01 87.34

Price Performance

Historical Comparison
ENTA
ISOU

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About ISOU IsoEnergy Ltd.

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.

Share on Social Networks: